Immunovant Inc. (IMVT)
NASDAQ: IMVT
· Real-Time Price · USD
15.96
-0.19 (-1.18%)
At close: May 01, 2025, 3:59 PM
16.50
3.35%
Pre-market: May 02, 2025, 05:37 AM EDT
Immunovant Revenue
Immunovant reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Immunovant generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
207
Market Cap
2.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|